Holen Sie sich die Stockscreener-App
89.72
0.55%
0.49
Handel nachbörslich:
87.98
-1.74
-1.94%
Schlusskurs vom Vortag:
$89.23
Offen:
$89.4
24-Stunden-Volumen:
663.24K
Relative Volume:
0.68
Marktkapitalisierung:
$7.50B
Einnahmen:
$1.31B
Nettoeinkommen (Verlust:
$215.20M
KGV:
36.43
EPS:
2.4627
Netto-Cashflow:
$408.32M
1W Leistung:
+5.29%
1M Leistung:
+5.75%
6M Leistung:
-6.28%
1J Leistung:
-16.32%
1-Tages-Spanne:
$87.87
$90.26
1-Wochen-Bereich:
$85.75
$90.61
52-Wochen-Spanne:
$72.76
$107.66
Healthequity Inc Stock (HQY) Company Profile
Firmenname
Healthequity Inc
Sektor
Branche
Telefon
801-727-1000
Adresse
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
Compare HQY vs VEEV, BTSG, TEM, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HQY
Healthequity Inc
|
89.72 | 7.46B | 1.31B | 215.20M | 408.32M | 2.4627 |
VEEV
Veeva Systems Inc
|
163.76 | 27.24B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.59 | 11.97B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
49.48 | 8.77B | 1.36B | -302.91M | -219.93M | -1.7182 |
HNGE
Hinge Health Inc
|
62.06 | 4.86B | 646.34M | -512.40M | 202.76M | -6.6871 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2026-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-05-22 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2025-03-25 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Outperform |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-04-02 | Bestätigt | JP Morgan | Overweight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-09-21 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-10-21 | Hochstufung | Goldman | Sell → Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-07-12 | Eingeleitet | Goldman | Sell |
| 2022-04-11 | Eingeleitet | Wells Fargo | Overweight |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-03-30 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-12-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-09-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2021-07-02 | Eingeleitet | Stephens | Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2021-01-07 | Eingeleitet | BTIG Research | Neutral |
| 2020-12-08 | Bestätigt | Barrington Research | Outperform |
| 2020-12-02 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-23 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-14 | Eingeleitet | Guggenheim | Buy |
| 2020-04-13 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-03-17 | Bestätigt | Barrington Research | Outperform |
| 2019-10-07 | Eingeleitet | Goldman | Neutral |
| 2019-09-09 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-07-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-06-05 | Bestätigt | BofA/Merrill | Neutral |
| 2019-03-01 | Bestätigt | BofA/Merrill | Neutral |
| 2019-02-07 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-02-07 | Hochstufung | SunTrust | Hold → Buy |
| 2018-12-06 | Herabstufung | SunTrust | Buy → Hold |
| 2018-09-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-05-23 | Eingeleitet | BofA/Merrill | Buy |
| 2018-04-24 | Fortgesetzt | JP Morgan | Overweight |
| 2018-03-20 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-12-06 | Bestätigt | Chardan Capital Markets | Buy |
Alle ansehen
Healthequity Inc Aktie (HQY) Neueste Nachrichten
GW&K Investment Management LLC Grows Position in HealthEquity, Inc. $HQY - MarketBeat
Motley Fool Wealth Management LLC Has $7.99 Million Stock Position in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity, Inc. $HQY Shares Bought by Axiom Investors LLC DE - MarketBeat
Rep. Gilbert Ray Cisneros, Jr. Buys HealthEquity, Inc. (NASDAQ:HQY) Shares - MarketBeat
The Bull Case For HealthEquity (HQY) Could Change Following Raised Earnings Outlook And Completed Buyback Program - Yahoo Finance
HealthEquity | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Zacks Industry Outlook Highlights BrightSpring Health Services, Biodesix and HealthEquity - Yahoo Finance
HealthEquity’s Healthcare Savings Powerhouse Moment: HSAs, AI & Mobile Drive Growth! - Smartkarma
Daily Brief Health Care: Parabilis Medicines, Integral Diagnostics, Healthequity Inc, ICON PLC, KT Medical Service, Leong Guan Holdings, Oramed Pharmaceuticals , Otsuka Holdings, Crism Therapeutics, TransCode Therapeutics and more - Smartkarma
1 in 3 Americans delay care for cost; workers lose 7.3 hours weekly - Stock Titan
HealthEquity Research Highlights Healthcare Affordability Issues Impacting American Workers - Quiver Quantitative
One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds - GlobeNewswire
One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds - GlobeNewswire Inc.
What HealthEquity (HQY)'s Strong Q1, Higher Guidance and Buybacks Mean For Shareholders - simplywall.st
Norges Bank Buys New Shares in HealthEquity, Inc. $HQY - MarketBeat
Number of shareholders of HealthEquity, Inc. – NASDAQ:HQY - TradingView
Cost of goods sold of HealthEquity Inc – XETR:2HE - TradingView
A Quick Look at Today's Ratings for HealthEquity(HQY.US), With a Forecast Between $108 to $125 - Moomoo
ETFs Investing in HealthEquity Inc Stocks - TradingView
Asset turnover of HealthEquity Inc – XETR:2HE - TradingView
HealthEquity Inc Cash Flow – XETR:2HE - TradingView
HealthEquity Inc Balance Sheet – XETR:2HE - TradingView
HealthEquity Inc Income Statement – XETR:2HE - TradingView
HealthEquity (NASDAQ:HQY) Upgraded at Wall Street Zen - MarketBeat
HealthEquity Inc stock (US42226C1071): Shares trade near recent highs after strong FY 2025 results - AD HOC NEWS
Westfield Capital Management Co. LP Raises Position in HealthEquity, Inc. $HQY - MarketBeat
HEALTHEQUITY INC (HQY) Stock Chart - ChartMill
(HQY) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY) - Yahoo Finance
Wall Street Analysts See a 33.49% Upside in HealthEquity (HQY): Can the Stock Really Move This High? - Yahoo Finance
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term - Yahoo Finance
HealthEquity announces CTO departure and transition of technology leadership - Investing.com
RBC Capital reiterates HealthEquity stock rating on growth outlook - Investing.com UK
RBC Capital reiterates HealthEquity stock rating on growth outlook By Investing.com - Investing.com South Africa
HealthEquity Inc (HQY) Shares Fall 3.5% -- What GF Score of 92 T - GuruFocus
HQY Reiterated by RBC Capital -- Price Target Maintained at $108 - GuruFocus
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - Yahoo Finance
Legal & General Group Plc Lowers Stake in HealthEquity, Inc. $HQY - MarketBeat
Healthequity Insider Sold Shares Worth $298,490, According to a Recent SEC Filing - marketscreener.com
HealthEquity (NASDAQ: HQY) EVP Fiore sells 3,142 shares under 10b5-1 plan - Stock Titan
HealthEquity director Wellborn Gayle Furgurson sells $219,510 in stock By Investing.com - Investing.com Australia
HealthEquity director Wellborn Gayle Furgurson sells $219,510 in stock - Investing.com
Healthequity EVP, general counsel, sells $675,000 in common stock - Investing.com India
Healthequity EVP, general counsel, sells $675,000 in common stock By Investing.com - Investing.com Canada
HealthEquity (HQY) director sells 2,439 shares in 10b5-1 trade - Stock Titan
HealthEquity (NASDAQ: HQY) EVP Ladd sells 7,500 shares in open-market trade - Stock Titan
Deutsche Bank Raises HealthEquity Price Target to $135 From $128, Maintains Buy Rating - Moomoo
HQY Maintained by Citizens -- Price Target Raised to $111.00 - GuruFocus
Citizens raises HealthEquity stock price target to $111 on margin outlook - Investing.com UK
Citizens raises HealthEquity stock price target to $111 on margin outlook By Investing.com - Investing.com South Africa
HealthEquity, Inc. (HQY) Stock Analysis: Exploring A 30% Upside Potential - DirectorsTalk Interviews
Finanzdaten der Healthequity Inc-Aktie (HQY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):